Indication
Treatment of anorexia, cachexia or unintended weight loss in adult patients with non-small cell lung cancer (NSCLC)
Loading your page…
Loading your page…
Cachexia;Anorexia;Carcinoma, Non-Small-Cell Lung
Marketing Authorisation Holder: Helsinn Birex Pharmaceuticals Ltd.
INN: anamorelin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Adlumiz: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.